JP2008542220A5 - - Google Patents

Download PDF

Info

Publication number
JP2008542220A5
JP2008542220A5 JP2008512759A JP2008512759A JP2008542220A5 JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5 JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008512759 A JP2008512759 A JP 2008512759A JP 2008542220 A5 JP2008542220 A5 JP 2008542220A5
Authority
JP
Japan
Prior art keywords
polymer
active substance
core
biologically active
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008512759A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008542220A (ja
JP5080453B2 (ja
Filing date
Publication date
Priority claimed from EP05028165A external-priority patent/EP1726299A3/en
Application filed filed Critical
Publication of JP2008542220A publication Critical patent/JP2008542220A/ja
Publication of JP2008542220A5 publication Critical patent/JP2008542220A5/ja
Application granted granted Critical
Publication of JP5080453B2 publication Critical patent/JP5080453B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008512759A 2005-05-27 2006-05-24 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法 Expired - Fee Related JP5080453B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05011516.1 2005-05-27
EP05011516 2005-05-27
EP05028165.8 2005-12-22
EP05028165A EP1726299A3 (en) 2005-05-27 2005-12-22 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
PCT/EP2006/004940 WO2006125620A2 (en) 2005-05-27 2006-05-24 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture

Publications (3)

Publication Number Publication Date
JP2008542220A JP2008542220A (ja) 2008-11-27
JP2008542220A5 true JP2008542220A5 (enExample) 2009-07-02
JP5080453B2 JP5080453B2 (ja) 2012-11-21

Family

ID=36935013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008512759A Expired - Fee Related JP5080453B2 (ja) 2005-05-27 2006-05-24 非経口投与に適したコアとマイクロカプセル並びにそれらの製造方法

Country Status (7)

Country Link
EP (2) EP1726299A3 (enExample)
JP (1) JP5080453B2 (enExample)
AT (1) ATE424190T1 (enExample)
CA (1) CA2609891A1 (enExample)
DE (1) DE602006005491D1 (enExample)
DK (1) DK1906928T3 (enExample)
WO (1) WO2006125620A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
GB0707612D0 (en) 2007-04-19 2007-05-30 Stratosphere Pharma Ab Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
BRPI0811784A2 (pt) 2007-05-23 2011-05-10 Allergan Inc colÁgeno reticulado e uso do mesmo
BRPI0811777A2 (pt) * 2007-05-23 2019-09-24 Allergan Inc partículas de ácido hialurõnico revestidas
US8318695B2 (en) 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
CN101896204B (zh) 2007-11-16 2015-05-20 爱力根有限公司 用于治疗紫癜的组合物及方法
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8394784B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
EP2544652A2 (en) 2010-03-12 2013-01-16 Allergan Industrie SAS A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition.
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
JP6009550B2 (ja) 2011-06-03 2016-10-19 アラーガン、インコーポレイテッドAllergan,Incorporated 抗酸化物質を含む皮膚充填剤組成物
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
ES2774051T3 (es) 2015-02-13 2020-07-16 Allergan Ind Sas Implantes para esculpir, aumentar o corregir características faciales, tales como la barbilla
WO2025137151A2 (en) 2023-12-18 2025-06-26 The Johns Hopkins University Dendrimer compositions for the treatment of atherosclerosis, obesity, and metabolic syndromes
CN118146569B (zh) * 2024-01-24 2024-11-22 中国海洋大学 透明质酸-青蒿琥酯-聚精氨酸纳米粒、制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
WO1992016191A1 (en) * 1991-03-25 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Long-acting pharmaceutical preparation
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
SE505146C2 (sv) 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
EP0994700A4 (en) * 1997-07-18 2000-10-18 Bayer Ag METHODS FOR REMOVING SOLVENT RESIDUES FROM COMPOSITIONS FOR THE NASAL ADMINISTRATION OF ACTIVE SUBSTANCES
SE9903236D0 (sv) 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
DE60040012D1 (de) * 1999-11-12 2008-10-02 Fibrogen Inc Rekombinantes gelatin in impstoffen
JP2004510730A (ja) * 2000-10-06 2004-04-08 ヤゴテック アーゲー 非経口的投与可能な制御放出微粒子調製物
ATE397020T1 (de) 2000-10-06 2008-06-15 Pacira Pharmaceuticals Inc Pharmazeutisch verwendbare stärke und deren herstellungsverfahren
JP2004510724A (ja) 2000-10-06 2004-04-08 ヤゴテック アーゲー 分子量の低下した澱粉からなる微粒子中に埋め込まれた免疫学的活性物質を含むワクチン組成物

Similar Documents

Publication Publication Date Title
JP2008542220A5 (enExample)
Li et al. pH-responsive lignin-based complex micelles: Preparation, characterization and application in oral drug delivery
Rao et al. Synthesis and Characterization of biodegradable Poly (Vinyl caprolactam) grafted on to sodium alginate and its microgels for controlled release studies of an anticancer drug
Tu et al. Alginate microparticles prepared by spray–coagulation method: Preparation, drug loading and release characterization
US9220689B2 (en) Nanoparticles
CN105494430B (zh) 一种载银低分子量壳聚糖复合微球抗菌剂及其制备方法
Liu et al. Fabrication of degradable polymer microspheres via pH-responsive chitosan-based Pickering emulsion photopolymerization
Wei et al. Halloysite nanotubes as particulate emulsifier: Preparation of biocompatible drug‐carrying PLGA microspheres based on pickering emulsion
Li et al. Functionalization of halloysite nanotubes by enlargement and hydrophobicity for sustained release of analgesic
CN109293976B (zh) 一种多孔壳聚糖微球的制备方法
CN100532438C (zh) 一种淀粉微球及其制备方法
de Matos Fonseca et al. Chitosan microparticles embedded with multi-responsive poly (N-vinylcaprolactam-co-itaconic acid-co-ethylene-glycol dimethacrylate)-based hydrogel nanoparticles as a new carrier for delivery of hydrophobic drugs
JP2005511335A5 (enExample)
CN101225179A (zh) 一种大面积有序多孔膜材料及其制备方法
JP4471655B2 (ja) 水系分散ヒドロキシプロピルメチルセルロースフタレートナノ粒子の製造方法
CN106832129A (zh) 一种衣康酸均聚物接枝羧甲基壳聚糖纳米粒的制备方法
CN102658072A (zh) 单分散壳聚糖中空微球的制备方法
He et al. Cagelike polymer microspheres with hollow core/porous shell structures
CN104127386B (zh) 一种大叶茜草素/壳聚糖纳米微球及其制备方法和应用
CN101564668B (zh) 微胶囊的制备方法
Tan et al. Preparation, characterization, and drug‐release properties of PEG‐DA‐based copolymer hydrogel microspheres
CN102631951B (zh) 一种制备具有高效催化性能的有机无机杂化纳米二氧化钛空心球的方法
CN105131157A (zh) 一种云母钛原位填充的聚苯乙烯银灰色保温材料的制备方法、其产品及应用
CN103894122B (zh) 可溶型药物负载微胶囊的制备方法
Hata et al. Preparation of hollow poly (divinyl benzene) particles with multiple holes in the shell by microsuspension polymerization with the SaPSeP method